EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 52013AE3335
Opinion of the European Economic and Social Committee on the ‘Amended proposal for a directive of the European Parliament and of the Council on the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of public health insurance systems’ COM(2013) 168 final — 2012/0035 (COD)
Opinion of the European Economic and Social Committee on the ‘Amended proposal for a directive of the European Parliament and of the Council on the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of public health insurance systems’ COM(2013) 168 final — 2012/0035 (COD)
Opinion of the European Economic and Social Committee on the ‘Amended proposal for a directive of the European Parliament and of the Council on the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of public health insurance systems’ COM(2013) 168 final — 2012/0035 (COD)
OJ C 271, 19.9.2013, p. 151–151
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
19.9.2013 |
EN |
Official Journal of the European Union |
C 271/151 |
Opinion of the European Economic and Social Committee on the ‘Amended proposal for a directive of the European Parliament and of the Council on the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of public health insurance systems’
COM(2013) 168 final — 2012/0035 (COD)
2013/C 271/29
On 8 April 2013 and 16 April 2013, respectively, the Council and the European Parliament decided to consult the European Economic and Social Committee, under Article 114 of the Treaty on the Functioning of the European Union, on the
Amended proposal for a Directive of the European Parliament and of the Council on the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of public health insurance systems
COM(2013) 168 final – 2012/0035 (COD).
Since the Committee has already set out its views on the content of the proposal in question in its opinion CESE 1573/2012, adopted on 12 July 2012 (1), it decided, at its 490th plenary session of 22 and 23 May 2013 (meeting of 22 May), by 161 votes to two with five abstentions, not to draw up a new opinion on the subject, but to refer to the position it had taken in the above-mentioned document.
Brussels, 22 May 2013.
The President of the European Economic and Social Committee
Henri MALOSSE
(1) EESC opinion on the Proposal for a Directive of the European Parliament and of the Council relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of public health insurance systems, OJ C 299 of 4.10.2012, p. 81.